Similarly, in April, a California jury ordered Takeda to pay $6.5 million in a damages to a diabetic man who claimed Actos caused his bladder cancer. The judge in that case also threw out the verdict.
Although not resulting in a win for the plaintiffs, the two jury verdicts are vindication for claims that Takeda failed to properly disclose Actos's link to bladder cancer. Takeda faces more than 3,000 other lawsuits over the drug. More than 1,200 of the cases have been consolidated in multi district litigation in Louisiana. The first of those cases goes to trial in January 2014.
 An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, Maryland.
 Feeley, J. "Takeda Failed to Properly Warn About Actos Risks, Jury Rules" Bloomberg Businessweek (September 26, 2013).